Validation, Implementation, and Clinical Utility of Whole Genome Sequence-Based Bacterial Identification in the Clinical Microbiology Laboratory

Author(s):  
Travis K. Price ◽  
Susan Realegeno ◽  
Ruel Mirasol ◽  
Allison Tsan ◽  
Sukantha Chandrasekaran ◽  
...  
2016 ◽  
Vol 54 (12) ◽  
pp. 2854-2856 ◽  
Author(s):  
John P. Dekker

Whole-genome sequence databases offer newin silicoapproaches for designing and validating PCR assays in the clinical microbiology laboratory. An article in this issue of theJournal of Clinical Microbiology(M. J. Jansen van Rensburg, C. Swift, A. J. Cody, C. Jenkins, and M. C. J. Maiden, J Clin Microbiol, 54:2882–2890, 2016,http://dx.doi.org/10.1128/JCM.01522-16) demonstrates the use of publicly available genomic sequence data to evaluate a PCR assay for distinguishingCampylobacterspecies.


1988 ◽  
Vol 1 (1) ◽  
pp. 19-26 ◽  
Author(s):  
C W Stratton

The serum bactericidal test represents one of the few in vitro tests performed in the clinical microbiology laboratory that combines the interaction of the pathogen, the antimicrobial agent, and the patient. Although the use of such a test antedates the antimicrobial era, its performance, results, and interpretation have been subject to question and controversy. Much of the confusion concerning the serum bactericidal test can be avoided by an understanding of the various factors which influence bactericidal testing. In addition, the methodologic aspects of the serum bactericidal test have recently been addressed and should place this test on firmer ground. New information on the clinical utility of this test is becoming available; additional data are needed to establish more clearly the usefulness of the serum bactericidal test in specific infections. Such clinical trials from multiple centers will enable firmer recommendations for the future use of the serum bactericidal test.


2018 ◽  
Vol 56 (9) ◽  
Author(s):  
Daniel D. Rhoads

ABSTRACT Whole-genome sequencing of bacterial isolates is increasingly being used to predict antibacterial susceptibility and resistance. Mason and coauthors describe the phenotypic susceptibility interpretations of more than 1,300 Staphylococcus aureus isolates tested against a dozen antistaphylococcal agents, and they compared these findings to susceptibility predictions made by analyzing whole-genome sequence data (J Clin Microbiol 56:e01815-17, 2018, https://doi.org/10.1128/JCM.01815-17). The genotype-phenotype susceptibility interpretations correlated in 96.3% (2,720/2,825) of resistant findings and 98.8% (11,504/11,639) of susceptible findings. This work by Mason and colleagues is helping to lower the barriers to using whole-genome sequencing of S. aureus in clinical microbiology practice.


2011 ◽  
Vol 44 (1) ◽  
pp. 104-109 ◽  
Author(s):  
Etienne Carbonnelle ◽  
Cécile Mesquita ◽  
Emmanuelle Bille ◽  
Nesrine Day ◽  
Brunhilde Dauphin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document